Figure 3.
Premature responses (mean +SEM) across 10 test sessions in the 2-CSRRT (a). STs made significantly more premature responses than GTs during baseline trials (Sessions 1–5, 7–9; ITIs 5s) and during probe trials (Sessions 6 and 10; ITIs 9s) (ps<0.05). Comparison of premature responses during baseline (averaged sessions 5 and 9) and probe trials (averaged session 6 and 10) (b).
